A dispute over cannabis supply contracts has spilled over to an Ontario courtroom, with a group of cannabis producers including Canopy Growth Corp. being sued for $500 million in damages by a group of shareholders behind a Leamington, Ont.-based greenhouse facility. 

The lawsuit alleges that Canopy Growth, the firm's venture arm Canopy Rivers Inc., as well as TerrAscend Corp. and its Canadian subsidiary, have committed “bad faith, fraud, civil conspiracy, breach of the duty of honesty and good faith in contractual obligations, and breach of fiduciary duty,” according to court documents. 

It seems that determining the value of cannabis seized by police is all about potential, with a bit of PR mixed in.

Which of These Pot Stocks to Watch is Showing the Most Momentum?

Led by surging cannabis sales, farm cash receipts in the first half of the year bucked the general decline caused by the coronavirus.

Receipts of $16.7 billion increased 5.2 per cent over 2019, says the Statistics Canada report.

Without a 62 per cent increase — $685 million — in cannabis sales, farm cash receipts would have increased a mere .8 per cent.

Higher crop receipts of $1.3 billion helped offset a $629 million decline in livestock sales. The decrease was caused by market restrictions when COVID-19 broke out.

Lentil receipts tripled to $604 million with better prices and increased exports to India and Turkey.

Canola returns jumped $249 million as China increased buying and more exports elsewhere offset lost Chinese markets.

As it seeks judicial relief from a run-in with the law last year in Kern County, Calif., hemp grower and researcher Apothio has decided to not merely move key parts of its business to the next city, county or state over—it’s hauling its research-and-development operations to North Bay, Ontario, thousands of miles away.

In the past six months, cannabis investors have focused mostly on U.S. marijuana stocks. This includes pot stocks like Green Thumb Industries Inc. (OTC:GTBIF) and Planet 13 Holdings Inc. (OTC:PLNHF). And while these pot stocks do have potential, investors seem to have lost focus on the Canadian cannabis industry.

Cronos Group Inc. appointed Kurt Schmidt to be its new chief executive officer on Wednesday in a move the cannabis producer said will help usher in a new phase of growth for the Toronto-based company. 

Schmidt, who has worked in the consumer packaged goods space for more than three decades at companies such as Blue Buffalo Company Ltd. and Nestlé S.A., replaces Mike Gorenstein, who will become Cronos' new executive chairman.